Large-scale testing (Phase 3)WithdrawnNCT01890772What this trial is testingVitamin D + Telaprevir + Peginterferon + Ribavirin for of Hepatitis C Genotype 1Who this might be right forHepatitis C Timothy Morgan, MD
Large-scale testing (Phase 3)Study completedNCT01433887What this trial is testingResponse to Pegylated Interferon and Ribavirin in Chinese Patients With Chronic Hepatitis C Genotypes 1 Versus 2/3 Versus 6Who this might be right forChronic Hepatitis C Third Affiliated Hospital, Sun Yat-Sen University 535
Large-scale testing (Phase 3)Study completedNCT02442284What this trial is testingEvaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in US Veterans With Genotype 1 Chronic Hepatitis C Virus InfectionWho this might be right forChronic Hepatitis CCirrhosisHepatitis C Virus AbbVie 99
Post-approval studies (Phase 4)UnknownNCT04997564What this trial is testingThe Efficacy and Safety of 12-week SOF/VEL Regimen Combined With Prophylactic Use of TAF for Treatment-naïve Genotype 1-6 HCV/HBV Co-infection Adult Patients With or Without Compensated Cirrhosis in ChinaWho this might be right forChronic Hepatitis CChronic Hepatitis B Peking University First Hospital 120
Large-scale testing (Phase 3)Study completedNCT01973049What this trial is testingUNITY 2: A Study of an Investigational Treatment Regimen of DCV+ASV+BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) With or Without RBV for 12 Weeks for the Treatment of Chronic Hepatitis C Virus(HCV)Genotype 1 Infection in Subjects With Compensated CirrhosisWho this might be right forHepatitis C Bristol-Myers Squibb 202
Not applicableStudy completedNCT02669940What this trial is testingObservational, Multi-Center Study of the Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in the Russian FederationWho this might be right forChronic Hepatitis CGenotype 1 AbbVie 158
Large-scale testing (Phase 3)Study completedNCT01728324What this trial is testingPhase 3 Study of BI 207127 in Combination With Faldaprevir and Ribavirin for Treatment of Patients With Hepatitis C Infection, Including Patients Who Are Not Eligible to Receive Peginterferon: HCVerso2Who this might be right forHepatitis C, Chronic Boehringer Ingelheim 496
Large-scale testing (Phase 3)Study completedNCT01716585What this trial is testingEvaluate Chronic Hepatitis C InfectionWho this might be right forChronic Hepatitis C Infection AbbVie (prior sponsor, Abbott) 636
Large-scale testing (Phase 3)Study completedNCT01715415What this trial is testingEvaluate Chronic Hepatitis C Infection in Treatment Experienced AdultsWho this might be right forChronic Hepatitis C Infection AbbVie (prior sponsor, Abbott) 395
Large-scale testing (Phase 3)Study completedNCT01725529What this trial is testingAn Efficacy, Pharmacokinetics, Safety and Tolerability Study of TMC435 as Part of a Treatment Regimen for Hepatitis C-Infected PatientsWho this might be right forHepatitis C, Chronic Janssen R&D Ireland 457
Testing effectiveness (Phase 2)Study completedNCT01012895What this trial is testingStudy to Determine the Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Failed Standard of CareWho this might be right forChronic Hepatitis C Bristol-Myers Squibb 215
Testing effectiveness (Phase 2)Study completedNCT00336479What this trial is testingPhase 2 Study of VX-950, Pegasys®, and Copegus® in Hepatitis CWho this might be right forChronic Hepatitis C Vertex Pharmaceuticals Incorporated 263
Testing effectiveness (Phase 2)Study completedNCT01685203What this trial is testingEvaluate the Safety and Effect of Co-administration of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Adults With Chronic Hepatitis C Virus InfectionWho this might be right forHepatitis C, Chronic AbbVie (prior sponsor, Abbott) 316
Large-scale testing (Phase 3)Study completedNCT02167945What this trial is testingEvaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) InfectionWho this might be right forChronic Hepatitis C Virus (HCV) Infection Genotype 1 AbbVie 615
Testing effectiveness (Phase 2)Study completedNCT01194037What this trial is testingA Phase 1b/2a Study of SC Hanferon™ in Combination With Ribavirin in Treatment-naïve Subjects With Genotype 1 Hepatitis CWho this might be right forChronic Hepatitis C InfectionGenotype 1 HanAll BioPharma Co., Ltd. 30
Testing effectiveness (Phase 2)Study completedNCT01439373What this trial is testingSafety, Antiviral Activity, and Pharmacokinetics of GSK2336805 With Peginterferon and Ribavirin in Chronic Hepatitis C SubjectsWho this might be right forHepatitis C, Chronic GlaxoSmithKline 16
Post-approval studies (Phase 4)Study completedNCT00356486What this trial is testingViral Kinetics of Treatment With Peginterferon Alpha-2a, Ribavirin and Epoetin β in Patients Coinfected HCV/HIVWho this might be right forHIV Infections Germans Trias i Pujol Hospital 74
Large-scale testing (Phase 3)Study completedNCT02123654What this trial is testingUNITY 3: A Japanese Phase 3 Study of a Daclatasvir/Asunaprevir/BMS-791325 in Subjects With Genotype 1 Chronic Hepatitis CWho this might be right forHepatitis C Virus Infection Bristol-Myers Squibb 297
Testing effectiveness (Phase 2)Study completedNCT01058512What this trial is testingA Trial of NOV-205 in Hepatitis C Patients Who Failed Standard TherapyWho this might be right forHepatitis C Cellectar Biosciences, Inc. 22
Not applicableStudy completedNCT01054742What this trial is testingObservational Study of Patients With Chronic Hepatitis C Virus (HCV) Infected With HCV Genotype 1 Low Virus Load (LVL 1) and Effect of PegIntron Plus Rebetol Treatment (Study P04793 Part 2)Who this might be right forHepatitis C Merck Sharp & Dohme LLC 2